Investitionsthese
Archangels focuses on investing in IP-rich tech and life sciences companies, particularly those with disruptive technology that is difficult for competitors to replicate. They prioritize businesses in Scotland, UK.
Investitionsphase
Early stage
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
IP-rich tech & life sciences companies with disruptive technology and protectable IP
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (23)
A
Adam A. Stokes
Academic in Residence
A
Adam Stokes
Senior Executive / Academic in Residence
A
Andrew Edward Sealey
Director
A
Andrew Sealey
Member Of The Board
A
Andris K. Berzins
Managing Partner
A
Athol Strachan
Member
B
Barry Sealey
Founder
C
Charles Sweeney
Chairman
D
Dan McKiddie
Investment Manager
D
Daniel McKiddie
Investment Manager
D
David Ovens
Joint Managing Director
E
Eric Young
Director
I
Ian Macleod
Chair
J
Jacqui McLaughlin
Non-executive Director
M
Maureen Kinsler
Board Member
M
Mike Rutterford
Founder
N
Nicholas Nelson
General Partner
N
Niki McKenzie
Joint Managing Director
P
Phil Harris
Non-executive Director
S
Sarah Hardy
Director, Head of New Investment
S
Shaolei McKie
Senior Investment Manager
T
Tim Allan
Board of Directors
T
Tim Allan CBE
Board Of Directors
